Indianapolis, IN, United States of America

Jefferson Ray McCowan

This inventor holds 19 USPTO granted patents and 1 published patent application and 2 EPO patents, primarily in Antithrombotic Agents. Top assignees: Eli Lilly and Company, Eli Lilly. Active years: 1991-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jefferson Ray McCowan. Retrieved from https://idiyas.com/inventor/jefferson-ray-mccowan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19 

% Patents Active = 78.9

 

Average Co-Inventor Count = 8.0

ph-index = 5

Forward Citations = 69(Granted Patents)


Company Filing History:


Years Active: 1991-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
AICARFT Inhibitors
Thrombin Inhibitors
5-HT6 Receptor Antagonists
Biphenyl Amide Lactam
Cycloalkyl Lactam Derivatives
Quinazolinone CCK Antagonists
Antithrombotic Diamines
Cancer Treatment
Formulations
Pharmaceuticals
Compounds
19 patents (USPTO):Explore Patents

Title: Jefferson Ray McCowan: Pioneering Innovator in the World of Patents

Introduction:

Jefferson Ray McCowan is a trailblazing inventor whose impact on the world of inventions and patents is truly remarkable. Hailing from Indianapolis, IN, his relentless pursuit of innovation serves as an inspiration to aspiring inventors worldwide.

Latest Patents:

Among his impressive portfolio of 19 patents, Jefferson Ray McCowan's latest inventions include groundbreaking compounds like the 1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds. These formulations have shown promising results as AICARFT inhibitors in the treatment of cancers, highlighting McCowan's commitment to advancing medical research. Additionally, his biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 showcase his innovative approach to developing pharmaceutical solutions for various health conditions.

Career Highlights:

Having worked at esteemed companies like Eli Lilly and Company, Jefferson Ray McCowan has left an indelible mark on the pharmaceutical industry through his inventive spirit. His contributions have not only improved treatment options for various diseases but have also set new standards for innovation in drug development.

Collaborations:

Throughout his career, McCowan has collaborated with talented individuals like Daniel Jon Sall and Matthew Joseph Fisher. These partnerships have led to the creation of novel compounds and formulations that have the potential to revolutionize the field of medicine.

Conclusion:

In conclusion, Jefferson Ray McCowan's dedication to pushing the boundaries of invention and patent development has earned him a well-deserved place among the pioneers of innovation. His work continues to inspire countless individuals to think creatively and make significant contributions to the world of patents and inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…